Publication | Open Access

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

Drug SafetyToxic Epidermal NecrolysisRecently Marketed DrugsMedicineAdverse Drug ReactionPoisoningToxicologyPharmacotherapyDermatologyPharmacologyStevens–johnson SyndromeClinical ToxicologyDrug Toxicity